On the flip side, ARK’s ARKG ETF parted with a significant stake in Adaptive Biotechnologies Corp (NASDAQ: ADPT ), selling 278,792 shares worth roughly $2.65 million. This sale continues a trend from ...

Investing.com -- Shares of MoonLake Immunotherapeutics soared 21.5% following reports that Merck (NSE: PROR) has engaged in discussions regarding a potential acquisition of the Swiss biotech firm for ...

Investors in Krystal Biotech, Inc. KRYS need to pay close attention to the stock based on moves in the options market lately. That is because the Dec. 19, 2025 $80.00 Call had some of the highest ...

Early-stage innovation in food systems can deliver both impact and returns, but only by adapting to the sector’s unique ...

The panelists laid out some reasons for optimism about the future of innovation in our state, and also some reasons for ...

Such dramatic price swings aren't unusual in the biotechnology industry; in this case, disappointing data from an important ...

The oncology giant will pay $1.5 billion to co-develop a BioNTech drug that targets the proteins PD-L1 and VEGF, following ...

Iowa State University leadership has joined universities, companies and other organizations across the U.S. in calling for ...

With our incredible universities, educated workforce and geographic location, I firmly believe Connecticut can be the next ...

Funding for a half-dozen tech hubs has been canceled in a setback for promising industrial policies. Local and regional ...

President Trump’s executive order aims to bring down drug prices while optimizing IP protections, and Congress should pass ...

Tony Locantro looks at the colourful journey of small cap investing and the stops on the way as we get well into the second quarter.